Verition Fund Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$676K	Sell	29,919 -55,470	-65%	-$1.23M	0.01%	1482
2025 Q4	$2.21M	Buy	+85,389	New	+$2.03M	0.01%	1514
2025 Q3	–	Sell	-27,662	Closed	-$661K	–	3954
2025 Q2	$661K	Buy	27,662 +8,345	+43%	+$210K	﹤0.01%	2765
2025 Q1	$480K	Sell	19,317 -6,748	-26%	-$162K	﹤0.01%	2609
2024 Q4	$491K	Sell	26,065 -6,723	-21%	-$118K	﹤0.01%	2498
2024 Q3	$493K	Buy	+32,788	New	+$561K	﹤0.01%	2332
2024 Q1	–	Sell	-10,254	Closed	-$346K	–	2943
2023 Q4	$346K	Sell	10,254 -1,220	-11%	-$35.7K	﹤0.01%	1722
2023 Q3	$352K	Buy	+11,474	New	+$414K	﹤0.01%	1636
2023 Q1	–	Sell	-8,433	Closed	-$326K	–	2494
2022 Q4	$326K	Buy	8,433 +4,315	+105%	+$210K	0.01%	1457
2022 Q3	$219K	Buy	+4,118	New	+$229K	﹤0.01%	2440
2022 Q2	–	Sell	-49,287	Closed	-$3.76M	–	2913
2022 Q1	$3.76M	Buy	49,287 +16,954	+52%	+$1.13M	0.07%	536
2021 Q4	$1.95M	Buy	+32,333	New	+$1.78M	0.02%	905
2017 Q2	–	Sell	-6,743	Closed	-$307K	–	1213
2017 Q1	$307K	Buy	+6,743	New	+$291K	0.03%	836